ICONIMAC

Pharmaceuticals for the purpose of treating life-threatening diseases; pharmaceuticals for use in the fields of biotechnology and immune therapeutics; pharmaceutical products, namely, innate immunity cell-based therapeutics; pharmaceuticals for the treatment of infectious disease, autoimmunity, neurodegeneration, and aging; pharmaceuticals for addressing underlying innate immune dysfunction, including in connection with infectious diseases, autoimmune diseases, neurologic diseases, cancer, Parkinson's, Alzheimer's, and dementia; pharmaceuticals for addressing a wide variety of diseases, including pulmonary diseases, fibrosis, and protein aggregation diseases; pharmaceutical preparations, namely, cell-based therapeutics to augment innate immune responses; pharmaceutical preparations, namely, a drug delivery system for the continuous release of a wide variety of therapeutic agents; vaccines; vaccine preparations

Biotechnology research; immune therapeutics research; research and development in the biotechnology and immune therapeutics fields; development of new technology in the field of biotechnology to augment innate immune responses; development of new biotechnology, namely, using augmented innate immune responses to promote the treatment of infectious disease, autoimmunity, neurodegeneration, and aging; development of new biotechnology, namely, pharmaceuticals for addressing underlying innate immune dysfunction, including in connection with infectious diseases, autoimmune diseases, neurologic diseases, cancer, Parkinson's, Alzheimer's, and dementia; development of new biotechnology, namely, pharmaceuticals for addressing a wide variety of diseases, including pulmonary diseases, fibrosis, and protein aggregation diseases; conducting clinical trials in the field of biotechnology; clinical research in the field of immune therapeutics; clinical research in the field of vaccines; research and development of vaccines and medicines; conducting research and clinical trials relating to innate immunity cell-based therapeutics; medical research services in the fields of biotechnology and immune therapeutics